BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16449481)

  • 1. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania.
    Allen MH; Hirschfeld RM; Wozniak PJ; Baker JD; Bowden CL
    Am J Psychiatry; 2006 Feb; 163(2):272-5. PubMed ID: 16449481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
    Hirschfeld RM; Bowden CL; Vigna NV; Wozniak P; Collins M
    J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of serum valproate concentration to response in mania.
    Bowden CL; Janicak PG; Orsulak P; Swann AC; Davis JM; Calabrese JR; Goodnick P; Small JG; Rush AJ; Kimmel SE; Risch SC; Morris DD
    Am J Psychiatry; 1996 Jun; 153(6):765-70. PubMed ID: 8633687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
    Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of oral loading of divalproex sodium in the treatment of acute mania.
    Martinez JM; Russell JM; Hirschfeld RM
    Depress Anxiety; 1998; 7(2):83-6. PubMed ID: 9614597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of lithium vs. valproate in the treatment of mania in the elderly: a retrospective study.
    Chen ST; Altshuler LL; Melnyk KA; Erhart SM; Miller E; Mintz J
    J Clin Psychiatry; 1999 Mar; 60(3):181-6. PubMed ID: 10192594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The valproate serum level in maintenance therapy for bipolar disorder in Japan.
    Machino A; Jitsuiki H; Okamoto Y; Izumitani S; Kimura Y; Suzuki K; Tanaka T; Inoue T; Koyama T; Wada K; Masaoka Y; Sasaki T; Yoshimura R; Nakamura J; Sumitan S; Ohmori T; Yamawaki S
    Hiroshima J Med Sci; 2013 Mar; 62(1):7-12. PubMed ID: 23600328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
    Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
    Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divalproex in the treatment of bipolar disorder.
    Keck PE; McElroy SL
    Psychopharmacol Bull; 2003; 37 Suppl 2():67-73. PubMed ID: 15021862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid reversal of corticosteroid-induced mania with sodium valproate: a case series of 20 patients.
    Roxanas MG; Hunt GE
    Psychosomatics; 2012; 53(6):575-81. PubMed ID: 23157995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose intravenous valproate in acute mania.
    Phrolov K; Applebaum J; Levine J; Miodovnick H; Belmaker RH
    J Clin Psychiatry; 2004 Jan; 65(1):68-70. PubMed ID: 14744171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
    Vasudev K; Goswami U; Kohli K
    Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial.
    Behzadi AH; Omrani Z; Chalian M; Asadi S; Ghadiri M
    Acta Psychiatr Scand; 2009 Dec; 120(6):441-5. PubMed ID: 19392814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of effectiveness of valproate in neuropsychiatry.
    Bowden CL
    Expert Rev Neurother; 2007 Jan; 7(1):9-16. PubMed ID: 17187491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic loading in the treatment of acute mania.
    Keck PE; McElroy SL; Bennett JA
    Bipolar Disord; 2000 Mar; 2(1):42-6. PubMed ID: 11254019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
    Adler CM; Fleck DE; Brecher M; Strakowski SM
    J Affect Disord; 2007; 100 Suppl 1():S15-22. PubMed ID: 17383737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
    Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
    Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate in bipolar disorder: 2000 onwards.
    Bowden CL; Singh V
    Acta Psychiatr Scand Suppl; 2005; (426):13-20. PubMed ID: 15833096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.